Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma
Clinical trial NCT03342300 · WITHDRAWN
Trial details
- NCT number
- NCT03342300
- Sponsor
- Peking University People's Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-06
- Primary completion
- 2020-11-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.